Enzyme treatment of foodstuffs for celiac sprue

US8962545B2 · kind B2 · utility

Assignee

• The Board of Trustees of the Leland Stanford Junior University · US

Inventors

• Felix Hausch · Munich, DE
• Gary Gray · Stanford, US
• Lu Shan · Houston, US
• Chaitan Khosla · Palo Alto, US

Key dates

• Filing date: Mar 21, 2011
• Grant date: Feb 24, 2015
• Expiry date: Jul 4, 2031

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.